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Background: The Proficiency Testing (PT) for Human Immunodeficiency Virus (HIV) using Lateral flow assays 
provides an avenue for participating institutions/individuals to assess their technical competence in testing for HIV 
using LFAs that are recommended in the National HIV Testing Algorithm (NHTA) in Kenya. It also provides confidence 
to the participating institutions and potential users of their services besides giving the institutions an opportunity for 
improvement.  
Objective: To determine the performance of selected HIV testing centers in a HIV PT Scheme in Kenya 
Methods: Fifty one participants (51) in Kenya were selected from 7 sites (Kisumu, Mombasa, Kilifi, Nairobi and 
Malindi) to participate in this PT round. The sites comprised both private sector and institutions that do not 
participate in the National HIV referral Lab-PT scheme. They were provided with panels containing six samples to 
analyze using the current NHTA in Kenya. Obtained results were sent to our laboratory electronically. 
Results: Eighty nine percent (89.0%) of the panels were correctly identified by the participants as positive or 
negative. Of the 11.0% errors, 74.2% were committed in one or more test result obtained while 12.9% committed in 
failure to follow NHTA. Two minor errors repeated by participants were; failure to record the final results in spite of 
obtaining correct tests and correct reactive results with the first and second test kits but in conclusion the participant 
recorded negative (12.9%). Root cause analysis revealed that the error committed by participants were as a result of 
failure to observe the kit manufactures’ instructions and NHTA guidelines.  
Conclusion: The results of this PT Scheme enhance the need for constant training of personnel conducting HIV testing 
and Counseling in Kenya on proper techniques of carrying out HIV testing using Lateral flow assays in the NHTA. 
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1. Introduction 
It is important that a HIV Testing Centers (HTC) and 
individual testers show competence in performing all 
HIV tests through External Quality Assessment 
(EQA)/Proficiency Testing (PT), on-site audit or blinded 
rechecking involving re-testing of 5-10% of negative 
samples and the positive samples at reference 
laboratory (WHO-Rapid HIV Tests Guidelines 2004). 
The PT for HIV Lateral flow assays (LFAs) provides an 
avenue for participating institution to assess their 
technical competence in testing for HIV using LFAs that 
are recommended in National HIV Testing Algorithm 
(NHTA). It provides assurance on participating 
laboratories/ and potential users of these laboratories' 
services with respect to precision, accuracy and 
sensitivity of detection.  
The scheme is not designed to evaluate the total 
operational competence of a laboratory on the basis of a 
set of predetermined criteria (Singapore National HIV 
Reference Laboratory Department of Pathology 2012).   
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LFA PT Scheme were introduced in Kenya in the year 
2007 by the National HIV Reference Laboratory 
(NHRL). This laboratory carries out Dried Tube 
Specimen (DTS)-based panels which are distributed 
three times per year to the testing sites enrolled in the 
LFA PT Scheme. Before 2011, site staff performed PT 
panels testing in group or testing was done by the most 
competent tester within the testing site. From 2011 up 
to now DTS panels have been distributed to individual 
HIV testers to assess their performance. Poor 
performing testers are targeted with quality 
intervention (Kitheka, 2012). In Kenya the LFA-PT 
activity carried out by NHRL between March and May 
2012 among 365 participants drawn from 289 facilities 
reported that 11.5% of the participants could not test 
all the panels correctly (WHO-Rapid HIV Tests 
Guidelines 2004, Kitheka, 2012). The program did a 
Root-cause analysis and established the following 
causes of failure: failure to follow approved NHTA 
(23%); lack of job aides (19%) in the facilities, lack of 
timers hence incorrect test timing, failure to adhere to 
written procedures, use of wrong sample volume, use of 
wrong test reagent and non-troubleshooting of invalid 
results (Kitheka, 2012).  
EQA Scheme in a NHRL in South India carried out in 
2012 showed that 97.13% reported correct results 
(Sushi, 2012). Livinus et al (2011) reported 
concordance of 82.0% in a pilot PT activity in Nigeria by 
using Dry Blood Spot (DBS) (Livinus et al, 2011). To 
complete a HIV test event successfully in PT scheme a 
participating laboratory is often required to achieve a 
score of at least 80% for Diagnostic Services or 100% 
for Donor Services. Failure of the testing program is 
defined as failing two of three consecutive test events 
(Wadsworth Centre, 2013).  
Various studies have shown that some laboratory staff 
experience difficulties in interpreting positive results 
that are close to being indeterminate where the 
accuracy of interpretation of 80-97% has been reported 
(Learmonth et al, 2008).  
This study aimed at determining the performance of 
selected HTCs in a HIV PT Scheme in Kenya. This study 
included assessing of both the testing facility and 
individual performance of laboratory staff and to 
provide analytical information to participating 
laboratories for self-evaluation. This study was also 
carried out as part of a wider project to develop the 
capacity of the Kenya Medical research  Institute 
(KEMRI) Production facility as the Centre of Excellence 
in production of various quality PT materials for the 
East African region. 
2. Methodology 
2.1 Number of participants and panels 
Fifty one participants (51) were selected from 7 sites: 
(KSM-1 and KSM-2 in Kisumu, MSA-1 and MSA-2 in 
Mombasa, KFI-1 in Kilifi, NBI-1 in Nairobi, MAL-1 and 
MAL-2 in Malindi) participated in this PT Round. The 
participants were those regularly involved in HIV 
screening from private sector and public institutions 
that do not participate in the NHRL-PT Scheme. The 
participants received a set of six (6) PT panels each 
round at an interval of four (4) months. Each time the 
participants received the panel was referred to as a PT 
round, and three rounds made up a PT program.  
In each PT round, panels from each pool were given a 
unique number (alphanumerical digit) that is only 
known to personnel in charge of the PT program for 
traceability and to avoid collusion of the results among 
the participants.  
2.2 Preparation of HIV DTS Panels 
HIV PT panels were prepared from serum (both HIV 
positive and HIV negative) obtained by re-calcification 
of the plasma harvested from waste blood units from 
Blood Transfusion Centers in Kenya as per the 
procedure described. Briefly, the plasma units were 
tested for Hepatitis B Virus (HBV) and HIV. All HBV 
positive units were discarded while retaining and 
distinguishing all the HBV negative units as being either 
HIV positive or negative. For the re-calcification of 
plasma, calcium chloride solution was added to each 
plasma unit and the mixture incubated in a water bath 
at 37°C for an hour. After forming a clot the mixture was 
placed overnight in a freezer at -20°C, and then 
removed. Then, serum solution filtered and heat 
inactivated. A green dye was added to the serum and 
dispensed into labeled serum tubes and left open in a 
safety cabinet to dry overnight (12 hours). The tubes 
were then capped and affixed appropriately with coded 
labels.  
Homogeneity Assessment of the Panel sera 
After labeling the panels 10% of them were randomly 
picked per pool and tested using the LFAs used by the 
participants at that period, to confirm their HIV status. 
The results obtained from this test were compared with 
the expected qualitative results of Enzyme-Linked 
Immunosorbent Assays (ELISA). 
External QC of the materials 
Panel sera from each of the six pools were sent to an ISO 
15189 accredited laboratory (KEMRI-CDC Kisumu) for 
external Quality Control and their status confirmed as 
concurrence.  
Shipping of the PT materials 
The DTS were transported to the selected site by the PT 
providing personnel. The content of the shipment 
included the six panel sera, instruction note and 
Delivery note. During this time the participants were 
trained on how to minimize the obvious errors in PT. 
The participants were also allowed to ask questions that 
bothered them. 
2.3 Sample Testing Procedure 
In each of the PT round the participants were to test the 
PT panels using the available test kit according to the 
NHTA. Each participant was expected to use a set of up 
to three sets of kits to identify the qualitative status of 
each panel. Therefore if a sample was non-reactive in 
the first kit the participant was to fill non-reactive in the 
form provided. Similarly if a sample was reactive in the 
first kit the participant was to test the same sample 
using the second kit and if it remains reactive he/she 
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was to conclude as reactive in the form. On the other 
hand a reactive sample on only the first kit with the 
second kit being non-reactive the participant was to be 
conclude as indeterminate (this option was only for 
those participants without the third test kit). The status 
of a sample that was reactive on the first kit but non-
reactive on the second kit, was to be determined by a 
third kit. The result of any two agreeable results out of 
the three test kits was considered the HIV status of the 
sample. Table 1 shows the test kits used during the PT 
program. 
2.4 Data management 
The data forms filled by each of the participating staff 
were collected by the supervisor and emailed to KEMRI 
and entered into one database, using the Microsoft 
Excel program and Statistical package for social 
scientist (SPSS).  The preliminary data entry was 
reviewed, and double checked through a data cleaning 
process by PT Providing Team before informing the 
participants of their performance. Thereafter the results 
were analyzed.  There were six types of errors assessed 
in this PT exercise namely: 
ETR (Error in Test kit Result): One or more 
individual test kit result obtained were wrong, and 
hence wrong conclusion 
EBC (Error with unclear Basis of Conclusion): Made 
correct conclusion on two positive samples, despite 
reporting the third test kit result as “invalid” 
EOC  (Error of Omitted Conclusion): correct 
individual test kit results were obtained but 
conclusion was omitted 
ECI-(Error in following Coding Instructions): correct 
test kit results and conclusion but had not used the 
provided codes, “Reactive” or “Non-reactive”, instead 
reported each test kit result as “positive” or 
“negative” 
ENE (Error No test kit result entered on the form). 
EAU (Error on Algorithm Used): the participant used 
a wrong algorithm during the testing, starting with a 
different test kit other than determine kit. 
The three errors were regarded to be of lesser gravity; 
errors associated with ECI, EAU and EOC results 
because the staff committed them after obtaining a 
correct individual HIV test kit results. For this reason 
we disaggregate these three categories of errors in our 
results presentation.   
Performance of the participant or the institution refers 
to the proportion of samples correctly tested and 
reported.  
2.5 Ethical considerations 
The ethical approval was given by KEMRI Scientific 
Steering Committee (Ref.: SSC No. 2190) and each 
participating lab filled a consent form before 
participating in the PT program. 
 3.  Results 
3.1 Participants profiling 
In all the three rounds, a total of 51 different individual 
participated in the PT program from 11 facilities. In the 
first, second and third rounds, there were 41, 18 and 16 
participants respectively and each received a set of six 
panel for each round.  
Majority of the participants were Laboratory 
technologists (94.3%) and the rest were supervisors 
and counselors; 3.5% and 1.9% respectively. 
In the first two PT rounds Determine™ HIV-1/2 kit was 
the first test kit followed by Uni-Gold™ HIV test, 
however in the last round the NHTA changed; health 
workers were to first test the samples using KHB 
Colloidal Gold and all reactive samples were to be 
confirmed using at least 1(one) or more other kits that 
included either first response and KHB Colloidal Gold.  
The third PT round was performed when the transition 
was in progress and there were therefore a number of 
test kits used based on availability. Table 1 shows the 
list of the kits that the participants used during the PT 
Rounds. Majority of the participants had KHB Colloidal 
Gold and First Response but there was scarcity of third 
test kit as observed in all facilities except two.  
 
Table 1: Test Kits and their status 
PT Round 
HIV test kits used 
 Status of panels 
distributed 
 Total number of  
panels distributed 
1st kit 2nd kit 3rd kit*  Positive Negative  Panel Participants 
Round 1 
Determine™ HIV-
1/2 
SD Bioline 
Uni-Gold™ 
HIV test 
 
82 82 
 
246 41 
Round 2 
Determine™ HIV-
1/2 
Uni-Gold™ 
HIV test 
Uni-Gold™ 
HIV test 
 
36 36 
 
108 18 
Round 3 
KHB Colloidal Gold/ 
Determine™ HIV-
1/2 
First 
Response™ 
Uni-Gold™ 
HIV test 
 
32 32 
 
48 16 
* Some labs did not have the third test kit 
 Muchiri et al, Afr. J. Pharmacol. Ther. 2016. 5(1): 21-27 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
24 
Table 2. Performance of various HIV panels 
PT Round Panels Number of Panels without any error (%) Panels with an error 
Round 1 Positive (n=123) 99 (80.4%) 24 (19.6%) 
 
Negative (n=123) 120 (97.6%) 3(2.4%) 
 
Total (n=246) 219(89.0%) 27(10.9%) 
Round 2 positive (n=54) 50(92.6%) 4(7.4%) 
 
Negative (n=54) 48(88.9%) 6(11.1%) 
 
Total (n=108) 98(90.7%) 10(9.3%) 
Round 3 Positive (n=60) 53(88.3%) 7(11.7%) 
 
Negative (n=30) 26(86.6%) 4((13.3%) 
 
Total (n=90) 78(87.8%) 11(12.2%) 
 
     Figure. 1: Performance of the participants on each panel PT round 
 
3.2 Performance of the participants 
The average performance of the participants in the 
three rounds was 90.6%; in which the first round the 
overall performance was 89.0%, it then rose to 90.7% in 
the second round and finally 92.3% in the last round 
(Table 2).  
3.3 Performance on each category of HIV panels 
The PT panels were qualitative with either positive or 
negative results in all the three rounds. 
The number of positive panels correctly tested without 
any error in round one was 80.4% and in round 2 it 
increased to 92.6% and then dropped to 88.3% (Table 
2). The overall performance when testing positive 
panels was 87.1%. In the negative panels, the first 
round has the highest number of panels tested without 
any error, this number gradually dropped to 86.6% in 
the third round (Figure 1). The overall performance for 
the negative panels was 91.0%, making it easier for the 
participant to correctly test the negative panels 
compared to the positive panels. 
3.4 Errors made by the participants 
There was observed an indirect proportionality 
between the errors and the PT rounds in that the 
number of errors decreased from five in round one to 
two different major errors in round three. On the other 
hand, there were ten different types of error made by 
the participants in the three rounds as listed in Table 3. 
In each round a set of new errors different from the 
previous one were observed such that in round two the 
participant had errors in conclusion and in round three 
the three types of errors (wrong application of 
algorithm, stated and type of test kits used not stated) 
were on the application of the test kits. 
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Table 3: Errors made by participants in each PT round 
Performance/Errors made 
PT round 1 
Status of panel 
 
PT round 2 
Status of panel 
 
PT round 3 
Status of panel 
Pos Neg Total  Pos Neg Total  Pos Neg Total 
No error made 99 120 219  50 48 98  52 26 78 
Errors made            
 
Error in the first test (determine) 1 - 1  - 1 1  - - - 
Error in second kit (Unigold) 
resulting in Indeterminate results 
13 - 13 
 
2 - 2 
 
- - - 
error in second kit (Unigold) wrong 
conclusion 
9 - 9 
 
- - - 
 
- - - 
Got correct kit Results but made 
wrong conclusion 
1 - 1 
 
- 1 1 
 
- - - 
Got correct results but no test kit 
results Entered 
- 3 3 
 
1 3 4 
 
- - - 
Got correct kit Results but made 
wrong conclusion 
- - - 
 
- 1 1 
 
- - - 
wrote correct conclusion despite of 
error in test results 
- - - 
 
- 1 1 
 
- - - 
wrong application of algorithm 
(Unigold kit as first Kit) 
- - - 
 
- - - 
 
4 2 6 
False positive, and the kit used not 
stated 
- - - 
 
- - - 
 
- 1 1 
Type of test kits used not stated - - -  - - -  4 1 5 
Total 123 123 246  54 54 108  60 30 90 
 
       Table 4: Errors Performed by the participating Institutions 
 
Error performed by the participant /panel sera 
Facility 
No error 
n (%) 
Had an Error 
n (%) 
Total 
NBI-1 24 (100.0%) - 24 
MAL-1 6 (100.0%) - 6 
KFI-1 18 (100.0%) - 18 
MSA-2 12 (100.0%) - 12 
MAL-2 2 (33.3%) 4 (66.7%) 6 
KSM-1 139 (92.7%) 11(7.3%) 150 
MSA-1 18 (60.0%) 12 (40.0%) 30 
Total 219 (89.0%) 27(11.0%) 246 
 
3.5 Errors in PT Round 1 
In round one of the PT program, out of 246 panels 
distributed with an equal number of positive and 
negatives, a higher number of errors were observed 
among the positive panel; 4/5 (80.0%) as compared to 
the negative panels.  There were 24 errors observed 
among the positives and three (3) among the negatives. 
Three out of the five (60%) errors committed were 
related to particular test kit, in which second test kit 
(UniGold) gave false negative results in 22/24 (91.7%) 
errors, and determine test kit gave 1/24 (4.2%) false 
negative results.  
The participants differed in how to conclude an ETR 
(Error in one Test kit Result) with one positive and the 
 Muchiri et al, Afr. J. Pharmacol. Ther. 2016. 5(1): 21-27 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
26 
other negative. More than half (59.1%) correctly 
concluded as indeterminate results and the rest 
concluded as negative results without using a tie 
breaker. Among the negative panels, one participant got 
correct results in each test but failed to record test kit 
conclusions. 
3.6 Errors in PT Round 2 and 3 
Round two had similar errors as round one but with 
lower frequencies (Table 3). The only different errors 
observed were on conclusion whereby the participant 
got correct kit Results but made wrong conclusion and 
the other wrote correct conclusion despite of error in 
test results.  
The type and number of errors in round three 
decreased to only two from five that were observed in 
round two.  Similarly the types of error shifted from kit 
related to personal and application related errors. The 
two errors done by the participants were wrong 
application of the national algorithm whereby the 
participant started with Unigold test kit and a 
participant failing to record the type of test kits they 
used (Table 3). 
3.7 Institutional Performance and reproducibility 
In Round 1, participants from institution MAL-2, KFI-1, 
NBI-1, and MSA-2 performed no error in any of the 
panel sera; they scored 100% in all the tests. MAL-2 and 
MSA-1 and KSM-1 committed 66.7%, 40.0% and 7.3% 
errors respectively (Table 4).  Out of the 27/246 
(11.0%) errors, 44.4% were from MSA-1, 40.7% from 
KSM-1 and 14.8% were performed by MAL-1. The 
errors performed by each institution were inter-related 
among the participants. 
3.8 Corrective actions taken to improve the errors 
observed  
After every round the PT providing team analyzed the 
data and sent back the result to the 
participant/institutions indicating the expected results 
and what the participant got. This was followed by 
training the participants on the common errors 
observed during the PTs. Through those trainings, it 
was realized that the participants who got 
indeterminate results never strictly followed the kit 
manufacturer’s user manuals especially on the time to 
read the results. Except on the new PT participants the 
error was eliminated by the third round of the PT 
(Table 3). 
4. Discussion 
HIV testing is a key component in control and 
management of the Virus. With the introduction of 
point-of-care testing technologies commonly referred as 
Voluntary Counseling and Testing (VCT) centers and 
sometimes involving  the  use  of  non-laboratory staff  
in  routine  testing  has  further  increased  the  
complexity  of  Quality Assurance (Alemnji  et al, 2011).  
There are two acceptable HIV diagnostic testing 
strategies: serial strategy or parallel strategy that 
includes two or more tests (Yan et al, 2014). Kenya 
being a high HIV prevalence country, parallel testing is 
the most acceptable option. During the time of 
administering the PT (mid 2014), the Kenyan NHTA 
used Determine™ HIV-1/2 (Abbott Diagnostic Division, 
Hoofddorp, The Netherlands), as the first kit followed 
by Uni-Gold™ HIV test (Trinity Biotech, Oregon, USA) as 
the second kit.  
Eighty nine percent (89.0%) of the DTS panels were 
correctly detected by the participants as clear positive 
or negative, whereas 11.0% had an error in detection 
using any of the two kits or applying the NHTA 
requirement. These results were very close to those 
found by the NHRL (Kenya) in the DTS-based HIV PT in 
2012 in which the rate of errors was found to be 11.5% 
(Kitheka, 2012). Better results have been obtained in 
the PT Program in developing countries such as India 
where the rates of detection of right results has been 
97.13% (Wadsworth Centre, 2013). There was 
progressive reduction of the errors obtained by the 
participants with increase in the number of 
participation in the PT program. This was initiated by 
training and constantly reminding the participants as 
part of the PT package. Through this model, a number of 
reasons for the errors obtained emerged in our root 
cause analysis. The main cause of error was improper 
application of the kit user manual especially on the 
waiting time. The participants read the results before 
the required time. In round three there was a drastic 
reduction in the number of mistakes performed by the 
participants.  From the participants’ results, mistakes 
performed were of lesser gravity with only one mistake 
of heavier gravity. More often than not, the lesser 
gravity mistakes do not necessarily lead to wrong 
screening of the sample; the mistakes usually violate the 
current HIV screening guidelines 
The most common errors performed by the participants 
in the three rounds were ETR (Error in one or more test 
kit resulting in indeterminate results. The second test 
kit gave more false negative results than was later 
found to be due to human errors. Conclusion of an 
indeterminate result was a challenge and some 
participants preferred concluding results as negative 
even without using a third tie breaker kit. Such error 
was later observed to be due to lack of structured 
referral system of any HIV controversial result within 
these facilities. Other common mistakes observed 
included inconsistence in reporting of results; one 
participant did not record the final staff results despite 
obtaining correct tests while another participant got 
correct reactive results in the first and second test kits 
but in conclusion the participant recorded negative.  
5. Conclusion 
There is a need for constant training of all the HIV point 
of care providers on HIV testing.  Our results and 
successes as PT providers were as a result of close 
monitoring and training of the participants during and 
after the PT round.  Such training and proper 
communication encouraged participants on how to 
improve their performance as it was observed at every 
PT round. The type of errors also shifted from major 
errors like obtaining false test kit results to minor 
operational errors such as failure to record test kits 
used in the third round. Therefore,  a  careful  approach  
towards  improvement  of  participants and laboratories  
that  encourages  best  practices,  and review of 
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government policies in point-of-care testing is needed 
to improve quality  of  testing  as  decentralization  takes  
place (Alemnji  et al, 2011). 
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